Kenvue Inc (KVUE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché KVUE Giù? Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Kenvue Inc Stock (KVUE) Company Profile

Consumer Defensive (252)

908-874-1200

1 KENVUE WAY, SUMMIT

Prossima data di guadagno

Ultimi documenti SEC

KVUE's Discussions on Twitter

Confronta KVUE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KVUE Kenvue Inc	18.99	35.45B	15.14B	1.42B	1.63B	0.74
PG Procter Gamble Co	157.90	368.28B	84.28B	16.07B	14.05B	6.51
UL Unilever Plc Adr	62.89	153.93B	64.99B	6.71B	6.53B	2.4495
CL Colgate Palmolive Co	83.28	67.24B	20.00B	3.05B	3.37B	3.56
KMB Kimberly Clark Corp	127.99	42.47B	18.88B	2.38B	2.10B	7.26

Kenvue Inc Stock (KVUE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-10	Iniziato	Redburn Atlantic	Neutral
2025-03-24	Iniziato	Evercore ISI	In-line
2025-01-06	Aggiornamento	Piper Sandler	Neutral → Overweight
2024-12-12	Downgrade	Deutsche Bank	Buy → Hold
2024-09-24	Iniziato	Jefferies	Buy
2024-09-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2024-05-28	Ripresa	Citigroup	Neutral
2024-04-11	Iniziato	Bernstein	Underperform
2024-04-03	Iniziato	William Blair	Mkt Perform
2024-03-01	Ripresa	Goldman	Neutral
2023-11-17	Iniziato	Piper Sandler	Neutral
2023-09-11	Aggiornamento	Deutsche Bank	Hold → Buy
2023-09-07	Iniziato	Canaccord Genuity	Buy
2023-09-06	Iniziato	Argus	Hold
2023-08-24	Aggiornamento	Goldman	Neutral → Buy
2023-07-25	Iniziato	Edward Jones	Buy
2023-06-01	Iniziato	HSBC Securities	Hold
2023-05-30	Iniziato	BofA Securities	Buy
2023-05-30	Iniziato	Citigroup	Neutral
2023-05-30	Iniziato	Deutsche Bank	Hold
2023-05-30	Iniziato	Exane BNP Paribas	Neutral
2023-05-30	Iniziato	Goldman	Neutral
2023-05-30	Iniziato	JP Morgan	Overweight
2023-05-30	Iniziato	RBC Capital Mkts	Outperform
2023-05-30	Iniziato	UBS	Neutral

Mostra tutto

Kenvue Inc Borsa (KVUE) Ultime notizie

Kenvue Inc Azioni (KVUE) Dati Finanziari

Kenvue Inc (KVUE)

Kenvue Inc Stock (KVUE) Company Profile

Confronta KVUE con altri titoli

Kenvue Inc Stock (KVUE) Upgrades & Downgrades

Kenvue Inc Borsa (KVUE) Ultime notizie

Strs Ohio Takes $57.36 Million Position in Kenvue Inc. $KVUE - MarketBeat

Advisors Capital Management LLC Purchases 597,396 Shares of Kenvue Inc. $KVUE - MarketBeat

Belpointe Asset Management LLC Grows Stock Holdings in Kenvue Inc. $KVUE - MarketBeat

Kenvue Inc. $KVUE Shares Purchased by Focus Partners Wealth - MarketBeat

Woodline Partners LP Sells 279,282 Shares of Kenvue Inc. $KVUE - MarketBeat

Kenvue Inc. $KVUE Position Boosted by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat

MBB Public Markets I LLC Buys New Holdings in Kenvue Inc. $KVUE - MarketBeat

Vident Advisory LLC Makes New Investment in Kenvue Inc. $KVUE - MarketBeat

Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy - MSN

Third Point LLC Purchases New Position in Kenvue Inc. $KVUE - MarketBeat

Alliancebernstein L.P. Acquires 395,785 Shares of Kenvue Inc. $KVUE - MarketBeat

Kenvue Sees Unusually High Options Volume (NYSE:KVUE) - MarketBeat

USS Investment Management Ltd Lowers Stock Position in Kenvue Inc. $KVUE - MarketBeat

Evercore ISI Issues Pessimistic Forecast for Kenvue (NYSE:KVUE) Stock Price - MarketBeat

Kenvue readying defense if Tylenol is cited in RFK Jr’s autism report: WSJ - MSN

In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reports - KEZI

Exclusive | CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report - The Wall Street Journal

Market Voices: Kenvue vs. RFK Jr., COVID shot safety, Lendbuzz IPO - MSN

Kenvue Met With RFK Jr. in Bid to Keep Tylenol Off Autism List - Bloomberg.com

Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report - Benzinga

Fortis Capital Advisors LLC Invests $797,000 in Kenvue Inc. $KVUE - MarketBeat

Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report - Stocktwits

Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports - Reuters

Kenvue mulls defense if Tylenol linked to autism (KVUE:NYSE) - Seeking Alpha

Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports - MarketScreener

Kenvue lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports - TipRanks

Kenvue CEO met with Robert F. Kennedy Jr. to argue there's no clear link between Tylenol and autismWSJ - MarketScreener

RFK Jr.’s planned report linking Tylenol to autism crashes shares of parent company Kenvue - MSN

October 31st Options Now Available For Kenvue (KVUE) - Nasdaq

Why Kenvue (KVUE) Is Down 9.7% After Potential US Warning on Tylenol Use in Pregnancy - simplywall.st

Is Kenvue Stock Underperforming the Dow? - Yahoo Finance

North America Pain Management Market to hit US$ 46.87 billion - openPR.com

Eventide Asset Management LLC Makes New $418,000 Investment in Kenvue Inc. $KVUE - MarketBeat

Is Kenvue Stock Underperforming The Dow? - Barchart.com

A Look at Kenvue's (KVUE) Valuation as Tylenol–Autism Reports Spark Investor Uncertainty - Yahoo Finance

Listerine promotes oral care products at FDI World Dental Congress - China Daily

DoubleLine ETF Adviser LP Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat

Kenvue Inc. $KVUE Shares Sold by Curi RMB Capital LLC - MarketBeat

Federation des caisses Desjardins du Quebec Has $8.71 Million Holdings in Kenvue Inc. $KVUE - MarketBeat

Amundi Acquires 444,376 Shares of Kenvue Inc. $KVUE - MarketBeat

Adage Capital Partners GP L.L.C. Increases Stock Position in Kenvue Inc. $KVUE - MarketBeat

Tylenol maker's stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a 'major overreaction' - Fortune

Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’ - Yahoo Finance

Kenvue Inc put volume heavy and directionally bearish - MSN

Kenvue sees ‘no causal link’ between acetaminophen use in pregnancy and autism - MSN

Kenvue, Inc. (KVUE) Gets a Hold from Deutsche Bank - The Globe and Mail

Concentric Capital Strategies LP Invests $3.73 Million in Kenvue Inc. $KVUE - MarketBeat

Kenvue, Inc. (KVUE) Gets a Buy from Bank of America Securities - The Globe and Mail

Goldman Sachs maintains Kenvue stock rating amid potential Tylenol report By Investing.com - Investing.com Australia

Kenvue Inc Azioni (KVUE) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a KVUE